Stocks · Health care · Pharmaceutical Preparations

Zymeworks Inc.

ZYME Clue Score44
United States Fiscal year ends December CIK 0001937653
25.79
+2.10%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
25.79 on 9 Oct 2026
31 24 16 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $18.11 14 Oct 2025 $18.23 15 Oct 2025 $18.62 16 Oct 2025 $18.55 17 Oct 2025 $18.40 20 Oct 2025 $18.32 21 Oct 2025 $17.93 22 Oct 2025 $17.67 23 Oct 2025 $17.41 24 Oct 2025 $17.74 27 Oct 2025 $18.47 28 Oct 2025 $19.30 29 Oct 2025 $19.38 30 Oct 2025 $19.12 31 Oct 2025 $19.09 3 Nov 2025 $18.89 4 Nov 2025 $18.16 5 Nov 2025 $18.05 6 Nov 2025 $17.90 7 Nov 2025 $16.46 10 Nov 2025 $18.05 11 Nov 2025 $19.68 12 Nov 2025 $19.37 13 Nov 2025 $18.50 14 Nov 2025 $18.52 17 Nov 2025 $23.90 18 Nov 2025 $22.99 19 Nov 2025 $22.60 20 Nov 2025 $23.82 21 Nov 2025 $24.02 24 Nov 2025 $24.99 25 Nov 2025 $26.18 26 Nov 2025 $27.33 28 Nov 2025 $26.71 1 Dec 2025 $26.03 2 Dec 2025 $25.10 3 Dec 2025 $26.22 4 Dec 2025 $26.52 5 Dec 2025 $26.69 8 Dec 2025 $26.41 9 Dec 2025 $25.81 10 Dec 2025 $25.87 11 Dec 2025 $24.94 12 Dec 2025 $25.48 15 Dec 2025 $25.97 16 Dec 2025 $25.85 17 Dec 2025 $25.59 18 Dec 2025 $26.40 19 Dec 2025 $27.23 22 Dec 2025 $27.62 23 Dec 2025 $26.79 24 Dec 2025 $26.86 26 Dec 2025 $26.87 29 Dec 2025 $26.74 30 Dec 2025 $26.54 31 Dec 2025 $26.33 2 Jan 2026 $26.62 5 Jan 2026 $25.48 6 Jan 2026 $24.18 7 Jan 2026 $24.85 8 Jan 2026 $23.10 9 Jan 2026 $23.17 12 Jan 2026 $23.16 13 Jan 2026 $23.92 14 Jan 2026 $24.62 15 Jan 2026 $23.63 16 Jan 2026 $23.47 20 Jan 2026 $23.67 21 Jan 2026 $23.95 22 Jan 2026 $23.55 23 Jan 2026 $23.24 26 Jan 2026 $22.91 27 Jan 2026 $23.25 28 Jan 2026 $22.31 29 Jan 2026 $22.38 30 Jan 2026 $22.53 2 Feb 2026 $23.17 3 Feb 2026 $23.44 4 Feb 2026 $23.11 5 Feb 2026 $22.02 6 Feb 2026 $22.72 9 Feb 2026 $22.51 10 Feb 2026 $22.73 11 Feb 2026 $22.83 12 Feb 2026 $23.17 13 Feb 2026 $22.60 17 Feb 2026 $23.07 18 Feb 2026 $22.91 19 Feb 2026 $23.32 20 Feb 2026 $22.72 23 Feb 2026 $22.99 24 Feb 2026 $23.63 25 Feb 2026 $24.12 26 Feb 2026 $23.81 27 Feb 2026 $23.29 2 Mar 2026 $23.31 3 Mar 2026 $24.45 4 Mar 2026 $25.23 5 Mar 2026 $24.80 6 Mar 2026 $24.08 9 Mar 2026 $24.25 10 Mar 2026 $25.46 11 Mar 2026 $25.14 12 Mar 2026 $23.23 13 Mar 2026 $22.88 16 Mar 2026 $23.62 17 Mar 2026 $24.04 18 Mar 2026 $23.45 19 Mar 2026 $23.90 20 Mar 2026 $23.32 23 Mar 2026 $24.02 24 Mar 2026 $23.60 25 Mar 2026 $24.23 26 Mar 2026 $24.69 27 Mar 2026 $24.18 30 Mar 2026 $24.21 31 Mar 2026 $25.04 1 Apr 2026 $25.94 2 Apr 2026 $25.80 6 Apr 2026 $25.84 7 Apr 2026 $26.00 8 Apr 2026 $26.71 9 Apr 2026 $27.35 10 Apr 2026 $26.32 13 Apr 2026 $26.17 14 Apr 2026 $26.98 15 Apr 2026 $27.73 16 Apr 2026 $27.20 17 Apr 2026 $27.80 20 Apr 2026 $27.85 21 Apr 2026 $28.27 22 Apr 2026 $28.53 23 Apr 2026 $27.43 24 Apr 2026 $28.10 27 Apr 2026 $28.56 28 Apr 2026 $27.94 29 Apr 2026 $27.83 30 Apr 2026 $27.54 1 May 2026 $26.61 4 May 2026 $26.78 5 May 2026 $26.68 6 May 2026 $27.61 7 May 2026 $26.60 8 May 2026 $23.89 11 May 2026 $24.03 12 May 2026 $23.90 13 May 2026 $24.57 14 May 2026 $23.96 15 May 2026 $23.93 18 May 2026 $24.43 19 May 2026 $24.40 20 May 2026 $24.84 21 May 2026 $25.11 22 May 2026 $25.61 26 May 2026 $25.40 27 May 2026 $24.79 28 May 2026 $25.48 29 May 2026 $25.13 1 Jun 2026 $24.54 2 Jun 2026 $24.11 3 Jun 2026 $24.35 4 Jun 2026 $25.10 5 Jun 2026 $24.04 8 Jun 2026 $23.93 9 Jun 2026 $23.26 10 Jun 2026 $22.85 11 Jun 2026 $22.97 12 Jun 2026 $22.88 15 Jun 2026 $23.26 16 Jun 2026 $22.49 17 Jun 2026 $23.14 18 Jun 2026 $23.14 22 Jun 2026 $23.26 23 Jun 2026 $23.88 24 Jun 2026 $24.30 25 Jun 2026 $23.77 26 Jun 2026 $24.15 29 Jun 2026 $24.10 30 Jun 2026 $26.14 1 Jul 2026 $25.72 2 Jul 2026 $26.31 6 Jul 2026 $25.33 7 Jul 2026 $26.72 8 Jul 2026 $26.65 9 Jul 2026 $27.07 10 Jul 2026 $25.88 13 Jul 2026 $24.94 14 Jul 2026 $24.66 15 Jul 2026 $24.66 16 Jul 2026 $24.19 17 Jul 2026 $24.19 20 Jul 2026 $23.76 21 Jul 2026 $24.05 22 Jul 2026 $23.36 23 Jul 2026 $23.12 24 Jul 2026 $22.86 27 Jul 2026 $23.00 28 Jul 2026 $22.61 29 Jul 2026 $22.01 30 Jul 2026 $22.71 31 Jul 2026 $21.94 3 Aug 2026 $21.81 4 Aug 2026 $22.79 5 Aug 2026 $23.50 6 Aug 2026 $23.13 7 Aug 2026 $23.54 10 Aug 2026 $24.16 11 Aug 2026 $24.32 12 Aug 2026 $24.93 13 Aug 2026 $25.76 14 Aug 2026 $25.12 17 Aug 2026 $25.31 18 Aug 2026 $26.07 19 Aug 2026 $27.21 20 Aug 2026 $26.57 21 Aug 2026 $28.67 24 Aug 2026 $28.77 25 Aug 2026 $27.47 26 Aug 2026 $29.31 27 Aug 2026 $29.01 28 Aug 2026 $28.27 31 Aug 2026 $29.41 1 Sep 2026 $29.67 2 Sep 2026 $31.05 3 Sep 2026 $29.90 4 Sep 2026 $29.19 8 Sep 2026 $28.11 9 Sep 2026 $27.15 10 Sep 2026 $26.44 11 Sep 2026 $26.24 14 Sep 2026 $26.85 15 Sep 2026 $26.05 16 Sep 2026 $26.24 17 Sep 2026 $27.48 18 Sep 2026 $26.57 21 Sep 2026 $26.81 22 Sep 2026 $27.57 23 Sep 2026 $27.50 24 Sep 2026 $26.81 25 Sep 2026 $26.52 28 Sep 2026 $27.12 29 Sep 2026 $27.20 30 Sep 2026 $26.49 1 Oct 2026 $25.96 2 Oct 2026 $25.15 5 Oct 2026 $26.21 6 Oct 2026 $25.65 7 Oct 2026 $26.53 8 Oct 2026 $25.26 9 Oct 2026 $25.79 Galbraith Kenneth Chair & CEO Sold at will $1.28M 22 Dec 2025 · at $27.02 · 26.3% of stake Smith Jeffrey T L EVP & Chief Medical Officer Sold at will $264.47K 5 Jan 2026 · at $25.10 · 36.5% of stake Moore Paul Andrew Chief Scientific Officer Sold at will $504.70K 5 Jan 2026 · at $25.10 · 39.2% of stake Galbraith Kenneth Chair & CEO Sold at will $1.36M 5 Jan 2026 · at $25.10 · 25.6% of stake Hollywood Mark EVP & Chief Operating Officer Sold at will $138.76K 12 Jan 2026 · at $22.67 · 4.4% of stake Smith Jeffrey T L EVP & Chief Medical Officer Sold at will $211.09K 12 Jan 2026 · at $22.67 · 25.8% of stake Moore Paul Andrew Chief Scientific Officer Sold at will $216.76K 12 Jan 2026 · at $22.67 · 16.5% of stake Galbraith Kenneth Chair & CEO Sold at will $689.82K 12 Jan 2026 · at $22.67 · 11.8% of stake Schayowitz Adam EVP, Head of R&D Sold at will $357.56K 9 Oct 2026 · at $25.85 · 37.3% of stake
0 buys9 sales at will0 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$105.97M
Net income
$81.13M
Free cash flow
$34.53M
Operating margin
-87.3%
Net margin
-76.6%
Return on equity
-30.2%
Return on capital
-27.2%
Revenue growth, 1 yr
38.9%
Revenue growth, 5 yr
22.2% a year

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
39M -181M FY20 Fiscal year 2020 Revenue $38.95M Net income $180.55M Margin -463.5% 27M -212M FY21 Fiscal year 2021 Revenue $26.68M Net income $211.84M Margin -794.0% · growth -31.5% 412M 124M FY22 Fiscal year 2022 Revenue $412.48M Net income $124.34M Margin 30.1% · growth +1,446.0% 76M -119M FY23 Fiscal year 2023 Revenue $76.01M Net income $118.67M Margin -156.1% · growth -81.6% 76M -123M FY24 Fiscal year 2024 Revenue $76.30M Net income $122.70M Margin -160.8% · growth +0.4% 106M -81M FY25 Fiscal year 2025 Revenue $105.97M Net income $81.13M Margin -76.6% · growth +38.9%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
9 Oct 2026 Schayowitz Adam
EVP, Head of R&D
Sold at will $357.56K 37.3%
12 Jan 2026 Galbraith Kenneth
Chair & CEO
Sold at will $689.82K 11.8%
12 Jan 2026 Moore Paul Andrew
Chief Scientific Officer
Sold at will $216.76K 16.5%
12 Jan 2026 Smith Jeffrey T L
EVP & Chief Medical Officer
Sold at will $211.09K 25.8%
12 Jan 2026 Hollywood Mark
EVP & Chief Operating Officer
Sold at will $138.76K 4.4%
5 Jan 2026 Galbraith Kenneth
Chair & CEO
Sold at will $1.36M 25.6%